MDT · 10-Q · 2026Q3 · Full report
Hugo Robotic Surgery Expansion
Medtronic plc · 2026-09-03 · Importance 31 · Surprise 32 · In source text
Surgical & Endoscopy sales increased 9%, supported by growth in LigaSure vessel sealing technology, V-Loc sutures, ProGrip mesh, the Hugo robotic-assisted surgery system, and Endoscopy. Medtronic expects global adoption of robotic-assisted surgery and broader use of Hugo in urologic, bariatric, gynecologic, hernia, and general surgery procedures. Touch Surgery Enterprise adds AI-powered surgical video and analytics capabilities to support performance analysis, training, and technique discovery. Hugo received U.S. FDA clearance for urologic procedures in December 2025, while LigaSure RAS received CE Mark in July 2025 for expanded gynecologic, general, and urologic applications.
Key facts
- The Hugo RAS system received U.S. FDA clearance for use in urologic surgical procedures in December 2025 and LigaSure RAS vessel-sealing technology received CE Mark in July 2025. source
- Surgical & Endoscopy net sales for the three months ended July 31, 2026 increased 9 percent compared to the corresponding period in the prior fiscal year. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | probable | — | The Hugo RAS system received U.S. FDA clearance for use in urologic surgical procedures in December 2025 and LigaSure RAS vessel-sealing… |